| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥24.7B | ¥16.9B | +46.0% |
| Operating Income | ¥7.4B | ¥2.8B | +166.0% |
| Ordinary Income | ¥7.1B | ¥2.4B | +199.6% |
| Net Income | ¥4.9B | ¥2.0B | +141.6% |
| ROE | 11.0% | 5.2% | - |
FY2026 Q2 results show robust growth with Revenue of 24.7B yen (YoY +46.0%), Operating Income of 7.4B yen (YoY +166.0%), Ordinary Income of 7.1B yen (YoY +199.6%), and Net Income of 4.9B yen (YoY +141.6%). The company achieved a gross profit margin of 50.9% and an operating margin of 29.8%, representing a significant profitability improvement. Operating cash flow reached 21.7B yen (YoY +342.0%), demonstrating strong cash generation capability that exceeded net income by 4.45 times. The company deployed 12.5B yen in capital expenditures while maintaining a cash position of 33.4B yen, indicating an active growth investment phase supported by increased long-term borrowings of 39.8B yen.
Revenue expanded 46.0% to 24.7B yen, driven by strong top-line growth across the business. The gross profit margin of 50.9% indicates high-value product or service offerings, while cost of sales increased to 12.1B yen in proportion to revenue growth. Selling, general and administrative expenses remained controlled at 5.2B yen, representing 21.1% of revenue, demonstrating operational leverage as the SG&A ratio improved with scale expansion. Operating income surged 166.0% to 7.4B yen with an operating margin of 29.8%, reflecting both revenue growth and improved cost efficiency. Non-operating items contributed a net negative 0.2B yen, primarily due to interest expenses of 0.3B yen on long-term debt, partially offset by foreign exchange gains of 0.1B yen. Ordinary income increased 199.6% to 7.1B yen. The gap between ordinary and net income of 2.2B yen reflects normal tax expenses, with no material extraordinary items reported. This represents a revenue up, profit up pattern with margin expansion, indicating effective operational leverage and cost management during the growth phase.
[Profitability] ROE of 11.0% reflects strong equity efficiency through the combination of high net profit margin of 19.7%, financial leverage of 2.22 times, and asset turnover of 0.252. Operating margin of 29.8% represents substantial improvement from operating leverage, while gross profit margin of 50.9% indicates strong pricing power or high-value offerings. EBITDA margin stands at 37.7% with EBITDA of 9.3B yen, confirming robust underlying profitability. [Cash Quality] Cash and deposits of 33.4B yen increased 17.7B yen YoY, providing short-term debt coverage of 27.9 times against current liabilities of 12.0B yen. Operating cash flow of 21.7B yen represents 4.45 times net income, demonstrating excellent cash conversion quality. [Investment Efficiency] Asset turnover of 0.252 remains low due to significant capital investment, with total assets reaching 98.3B yen. Capital expenditures of 12.5B yen represent 6.45 times depreciation of 1.9B yen, indicating an aggressive growth investment cycle. [Financial Health] Equity ratio of 45.1% provides moderate financial stability with total equity of 44.3B yen. Current ratio of 402.9% indicates exceptional short-term liquidity. Debt-to-equity ratio of 0.90 and long-term loans of 39.8B yen represent increased leverage to fund growth, with net debt to EBITDA of 0.68 times and interest coverage of 22.3 times maintaining adequate debt serviceability.
Operating cash flow of 21.7B yen represents 4.45 times net income and demonstrates strong cash-backed earnings quality. The operating CF conversion rate of 2.33 times EBITDA confirms robust cash generation capability from core operations. Investing cash flow of negative 12.7B yen was primarily driven by capital expenditures of 12.5B yen, reflecting substantial facility or equipment investments to support business expansion. Free cash flow of 9.0B yen indicates the company maintains positive cash generation even after aggressive capital deployment. Financing cash flow of 8.5B yen reflects new long-term borrowings that increased the loan balance by 8.4B yen to 39.8B yen, providing additional funding for the growth investment phase. The combination of strong operating cash flow and debt financing enabled cash and deposits to increase 17.7B yen to 33.4B yen, substantially strengthening the liquidity position. The cash generation strength provides financial flexibility, though working capital efficiency requires attention as accounts receivable increased 2.6B yen and inventory positions expanded.
Ordinary income of 7.1B yen versus operating income of 7.4B yen reflects a non-operating net negative contribution of approximately 0.2B yen, comprising interest expenses of 0.3B yen on long-term debt and foreign exchange gains of 0.1B yen. Non-operating expenses represent 1.6% of revenue, with interest costs at 1.2% of revenue reflecting the debt-funded growth strategy. Operating cash flow significantly exceeds net income with a ratio of 4.45 times, indicating highly cash-generative earnings with minimal accruals. The cash conversion rate of 2.33 times EBITDA further confirms earnings quality. However, accounts receivable increased 64.4% to 6.7B yen, faster than revenue growth, with DSO extending to 99 days, and work-in-process inventory at 2.6B yen resulted in CCC of 157 days, suggesting working capital efficiency deterioration that warrants monitoring for potential cash flow headwinds.
Full-year guidance projects revenue of 50.5B yen (YoY +40.2%), operating income of 10.7B yen (YoY +63.3%), ordinary income of 10.1B yen (YoY +78.7%), and net income of 7.0B yen (YoY -4.7%). Q2 cumulative progress rates stand at 49.0% for revenue, 68.9% for operating income, 70.6% for ordinary income, and 69.6% for net income against full-year targets. Operating and ordinary income progress rates exceed the standard 50% benchmark, indicating strong first-half performance. Net income guidance shows a year-over-year decline despite operating profit growth, likely reflecting higher tax burden normalization or increased depreciation from the substantial capital investments. The operating income guidance implies H2 operating income of 3.3B yen versus H1 of 7.4B yen, suggesting expected seasonal softness or conservative assumptions for the second half.
Working capital deterioration poses operational risk as accounts receivable increased 64.4% with DSO at 99 days and cash conversion cycle extended to 157 days, potentially constraining cash flow if sales growth slows or collection efficiency does not improve. High financial leverage with debt-to-EBITDA of 4.27 times and long-term loans of 39.8B yen creates refinancing and interest rate risk, particularly as the company is in a capital-intensive growth phase with CapEx at 6.45 times depreciation. Execution risk on aggressive capital investments of 12.5B yen requires successful facility ramp-up and capacity utilization to generate expected returns, with any delays in revenue realization potentially impacting profitability and cash flow generation against elevated fixed cost base and debt service obligations.
[Industry Position] (Reference - Proprietary Analysis) The company demonstrates superior profitability versus the manufacturing industry median. Net profit margin of 19.7% significantly exceeds the industry median of 5.4% (2025-Q2), and operating margin of 29.8% substantially outperforms the industry median of 8.8%, positioning the company in the top quartile for profitability. ROE of 11.0% exceeds the industry median of 4.4%, reflecting stronger equity efficiency. Revenue growth of 46.0% substantially surpasses the industry median of 11.7%, indicating exceptional top-line momentum. However, asset turnover of 0.252 trails the industry median of 0.36, suggesting capital intensity from the growth investment phase. Receivables turnover at 99 days is comparable to the industry median of 105 days but requires improvement. The equity ratio of 45.1% aligns closely with the industry median of 48.6%, indicating similar capital structure positioning. Current ratio of 402.9% significantly exceeds the industry median of 2.74 times, demonstrating superior liquidity management. Financial leverage of 2.22 times is above the industry median of 1.72 times, reflecting the debt-funded growth strategy. (Industry: Manufacturing (7 companies), Comparison: Prior fiscal periods, Source: Proprietary analysis)
Exceptional profitability and cash generation distinguish the company from manufacturing industry peers, with operating margin of 29.8% and net profit margin of 19.7% substantially exceeding industry medians, combined with operating cash flow 4.45 times net income demonstrating high-quality earnings. The company is executing an aggressive growth investment strategy with capital expenditures of 12.5B yen (6.45 times depreciation) funded by increased borrowings, creating a critical inflection point where successful deployment will drive sustained value creation while execution risks warrant close monitoring of capacity utilization and return on invested capital. Working capital efficiency deterioration with DSO at 99 days and cash conversion cycle of 157 days represents a key area requiring operational improvement, though the strong cash position of 33.4B yen and robust operating cash flow provide a buffer, making working capital management and deleveraging progress the primary factors to monitor for sustained performance.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.